During the past decade, Ospedale Morgagni-Pierantoni conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 7 clinical trials were completed, i.e. on average, 43.8% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Morgagni-Pierantoni" #1 sponsor was "Boehringer Ingelheim" with 5 trials, followed by "Heart Care Foundation" with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "University Hospital of Ferrara" with 2 trials sponsored and "Azienda Unità Sanitaria Locale della Romagna" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Morgagni-Pierantoni" #1 collaborator was "ASST Cremona" with 1 trials as a collaborator, "AUSL Romagna Rimini" with 1 trials as a collaborator, "Arcispedale Santa Maria Nuova-IRCCS" with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Morgagni-Pierantoni" are "Idiopathic Pulmonary Fibrosis" (6 trials), "Acute Coronary Syndrome" (3 trials), "Lung Diseases, Interstitial" (2 trials), "Acute Coronary Syndromes" (1 trials) and "Acute Pulmonary Embolism" (1 trials). Many other conditions were trialed in "Ospedale Morgagni-Pierantoni" in a lesser frequency.

Most popular intervention types in "Ospedale Morgagni-Pierantoni" are "Drug" (14 trials), "Procedure" (4 trials), "Other" (2 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Nintedanib" (4 trials), "PRM-151 (Zinpentraxin Alfa)" (2 trials), "Acute coronary syndrome and PCI and AF" (1 trials) and "Clinical data collection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Morgagni-Pierantoni" are 26 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Ospedale Morgagni-Pierantoni". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Ospedale Morgagni-Pierantoni, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Morgagni-Pierantoni, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".